Murad Essatari, Consultant Anatomical Pathologist, Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia
In one study, 74.2% of patients on a GLP-1 reported GI symptoms
Additionally, real-world data reveals that approximately 77.1% of participants achieved at least a 5% reduction in body weight after 104 weeks of treatment, highlighting its effectiveness in practical settings
If you have any questions or need the right support, including medical advice, Healthon is here for you all day, every day
Alli offers a lower-risk, simpler routeno prescription or injection, but more modest results (35%)
When calorie intake drops 30-50% (common on GLP-1 drugs due to appetite suppression), the body increases muscle protein breakdown to meet energy demands